Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of pharmacal research

• Publication date

  2011-12-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s12272-011-1103-2PMID 22139682
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican Mestizos.

  2011cited by this paper
• Pharmacogenomic biomarkers: new tools in current and future drug therapy.

  2011cited by this paper
• Analysis of CYP3A4 genetic polymorphisms in Han Chinese

  2011cited by this paper
• Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient.

  2011cited by this paper
• CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction.

  2010cited by this paper
• Discovery of the nonfunctional CYP2D6*31 allele in Spanish, Puerto Rican, and US Hispanic populations

  2010cited by this paper
• Elucidation of CYP2D6 Genetic Diversity in a Unique African Population: Implications for the Future Application of Pharmacogenetics in the Xhosa Population

  2010cited by this paper
• Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement

  2010cited by this paper
• Pharmacogenomics: a systems approach

  2010cited by this paper
• Characterization of the genetic profile of CYP2C19 in two South African populations.

  2010cited by this paper
• CYP1A2 is more variable than previously thought: a genomic biography of the gene behind the human drug-metabolizing enzyme

  2010influential reference
• Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese

  2009cited by this paper
• The CYP3A4*18 Genotype in the Cytochrome P450 3A4 Gene, a Rapid Metabolizer of Sex Steroids, Is Associated With Low Bone Mineral Density

  2009cited by this paper
• Polymorphism of human cytochrome P450 enzymes and its clinical impact

  2009cited by this paper
• Identification of New CYP2C19 Variants Exhibiting Decreased Enzyme Activity in the Metabolism of S-Mephenytoin and Omeprazole

  2009cited by this paper
• Discovery of Novel Functional Variants and Extensive Evaluation of CYP2D6 Genetic Polymorphisms in Koreans

  2009cited by this paper
• CYP2D6: novel genomic structures and alleles

  2009cited by this paper
• Two Novel CYP2D6*10 Haplotypes As Possible Causes of a Poor Metabolic Phenotype in Japanese

  2009cited by this paper
• Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects

  2009cited by this paper
• Pharmacogenomics of adverse drug reactions: practical applications and perspectives.

  2009cited by this paper
• A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo

  2009influential reference
• Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A–B, 18, 27, 36, 39, 47–51, 53–55, and 57)

  2008cited by this paper
• Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China.

  2008cited by this paper
• A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent

  2008cited by this paper
• Genetic Variations of CYP2C9 in 724 Japanese Individuals and Their Impact on the Antihypertensive Effects of Losartan

  2008cited by this paper
• The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements

  2008cited by this paper
• Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent

  2008cited by this paper
• A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China.

  2008cited by this paper
• A Natural Variant of the Heme-Binding Signature (R441C) Resulting in Complete Loss of Function of CYP2D6

  2007cited by this paper
• Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese

  2006cited by this paper
• NEW CYTOCHROME P450 2D6*56 ALLELE IDENTIFIED BY GENOTYPE/PHENOTYPE ANALYSIS OF CRYOPRESERVED HUMAN HEPATOCYTES

  2006cited by this paper
• A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) ina patient on warfarin therapy

  2006cited by this paper
• A silent mutation (2939G>A, exon 6; CYP2D6*59) leading to impaired expression and function of CYP2D6

  2006cited by this paper
• Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer

  2006cited by this paper
• Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations

  2006cited by this paper
• Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice

  2006cited by this paper
• A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

  2006cited by this paper
• FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION

  2005influential reference
• CHARACTERIZATION OF NOVEL CYP2A6 POLYMORPHIC ALLELES (CYP2A6*18 AND CYP2A6*19) THAT AFFECT ENZYMATIC ACTIVITY

  2005influential reference
• Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population.

  2005cited by this paper
• Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

  2005cited by this paper
• Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13

  2005cited by this paper
• Cytochrome P450: Structure, Mechanism, and Biochemistry, 3rd ed Edited by Paul R. Ortiz de Montellano (University of California, San Francisco). Kluwer Academic/Plenum Publishers: New York. 2005. xx + 690 pp. $149.00. ISBN 0-306-48324-6.

  2005cited by this paper
• CYP2C9 Haplotype Structure in European American Warfarin Patients and Association with Clinical Outcomes

  2005cited by this paper
• Functional Characterization of Novel Allelic Variants of CYP2C9 Recently Discovered in Southeast Asians

  2005cited by this paper
• ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS

  2005cited by this paper
• Three haplotypes associated with CYP2A6 phenotypes in Caucasians

  2005cited by this paper
• Cytochrome P450 activation of arylamines and heterocyclic amines.

  2005cited by this paper
• CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population

  2005cited by this paper
• FUNCTIONAL CHARACTERIZATION OF FIVE NOVEL CYP2C8 VARIANTS, G171S, R186X, R186G, K247R, AND K383N, FOUND IN A JAPANESE POPULATION

  2005cited by this paper
• Two novel single nucleotide polymorphisms (SNPs) of the CYP2D6 gene in Japanese individuals.

  2005cited by this paper
• Genetic variations and haplotypes of CYP2C19 in a Japanese population.

  2005cited by this paper
• Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism.

  2004cited by this paper
• A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo

  2004cited by this paper
• Functional impact of CϒP2C9*5, CϒP2C9*6, CϒP2C9*8, and CϒP2C9*11 in vivo among black Africans

  2004cited by this paper
• Six Novel Nonsynonymous CYP1A2 Gene Polymorphisms: Catalytic Activities of the Naturally Occurring Variant Enzymes

  2004cited by this paper
• Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.

  2004cited by this paper
• Discovery of new potentially defective alleles of human CYP2C9.

  2004cited by this paper
• Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.

  2004cited by this paper
• A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a Japanese subject with lowered capacity of mephobarbital 4'-hydroxylation.

  2004cited by this paper
• Novel CYP2C9 genetic variants in asian subjects and their influence on maintenance warfarin dose

  2004cited by this paper
• Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population

  2004cited by this paper
• Functional characterization of four allelic variants of human cytochrome P450 1A2.

  2004cited by this paper
• Novel nonsynonymous single nucleotide polymorphisms in the CYP2D6 gene.

  2004cited by this paper
• Identification of a novel variant CYP2C9 allele in Chinese.

  2004cited by this paper
• Cytochromes P450, drugs, and diseases.

  2003influential reference
• CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism.

  2003cited by this paper
• Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution.

  2003cited by this paper
• Pharmacogenetics of the major polymorphic metabolizing enzymes

  2003cited by this paper
• A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity.

  2003cited by this paper
• An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles.

  2002cited by this paper
• Twenty one novel single nucleotide polymorphisms (SNPs) of the CYP2A6 gene in Japanese and Caucasians.

  2002cited by this paper
• Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.

  2002cited by this paper
• Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.

  2002cited by this paper
• Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: allele frequencies and a novel *14B allele in mainland Chinese.

  2002cited by this paper
• Mutation analysis of the human CYP3A4 gene 5' regulatory region: population screening using non-radioactive SSCP.

  2002cited by this paper
• Common allelic variants of cytochrome P4503A4 and their prevalence in different populations.

  2002cited by this paper
• Identification and functional characterization of new potentially defective alleles of human CYP2C19.

  2002cited by this paper
• Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions.

  2002cited by this paper
• CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes.

  2002cited by this paper
• CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes.

  2002cited by this paper
• CYP3A4 gene polymorphisms influence testosterone 6beta-hydroxylation.

  2002cited by this paper
• A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.

  2002cited by this paper
• Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism.

  2002cited by this paper
• Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

  2001cited by this paper
• Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.

  2001cited by this paper
• Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans.

  2001cited by this paper
• Identification and functional characterization of eight CYP3A4 protein variants.

  2001cited by this paper
• Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos.

  2001cited by this paper
• A novel single nucleotide polymorphism altering stability and activity of CYP2a6.

  2001cited by this paper
• Genetic polymorphisms and functional characterization of the 5′‐flanking region of the human CYP2C9 gene: In vitro and in vivo studies

  2001cited by this paper
• Five novel natural allelic variants—951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)—of the human CYP1A2 gene in a French Caucasian population

  2001cited by this paper
• Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity.

  2001cited by this paper
• Human cytochrome P450 2A6 is the major enzyme involved in the metabolism of three alkoxyethers used as oxyfuels.

  2001cited by this paper
• CYP2A6*6, a Novel Polymorphism in Cytochrome P450 2A6, Has a Single Amino Acid Substitution (R128Q) That Inactivates Enzymatic Activity*

  2001cited by this paper
• Novel mutations of CYP3A4 in Chinese.

  2001cited by this paper
• CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians

  2000cited by this paper
• CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity

  2000cited by this paper
• Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus.

  2000cited by this paper
• Pharmacogenomics: translating functional genomics into rational therapeutics.

  1999cited by this paper

• Molecular Insights into CYP19A1 Mutations and Their Role in Estrogen Production.

  2025cites this paper
• Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review

  2024cites this paper
• Model‐based meta‐analysis of ethnic differences and their variabilities in clearance of oral drugs classified by clearance mechanism

  2023cites this paper
• Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders

  2023cites this paper
• Functional Characterization of Allelic Variations of Human Cytochrome P450 2C8 (V181I, I244V, I331T, and L361F)

  2023cites this paper
• Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.

  2022cites this paper
• Genetic variations and epigenetic modulations in CYP genes: Implications in NSAID-treatment of arthritis patients

  2021cites this paper
• Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics

  2021cites this paper
• Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease.

  2021cites this paper
• The role of pharmacogenomics in adverse drug reactions

  2019cites this paper
• Genetic diversity of cytochrome P450 1A2 with different metabolic activities in domestic cats

  2019cites this paper
• Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinsonʼs Disease

  2019cites this paper
• Genetic diversity of cytochrome P450 3A with different metabolic activity in domestic cats

  2019cites this paper
• Functional Characterization of Pharmcogenetic Variants of Human Cytochrome P450 2C9 in Korean Populations

  2019cites this paper
• Sirtuins in Alzheimer’s Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics

  2019cites this paper
• Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics

  2019cites this paper
• Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.

  2018cites this paper
• Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine

  2018cites this paper
• In vitro functional analysis of human cytochrome P450 2A13 genetic variants: P450 2A13*2, *3, *4, and *10

  2018cites this paper
• The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics

  2017cites this paper
• Metabolic Activation and Toxicities of bis-Benzylisoquinoline Alkaloids

  2017cites this paper
• Effects of CYP2C19 variants on methadone metabolism in vitro.

  2017cites this paper
• Biochemical analysis of recombinant CYP4A11 allelic variant enzymes: W126R, K276T and S353G.

  2016cites this paper
• Flavonoids and Naphthoflavonoids: Wider Roles in the Modulation of Cytochrome P450 Family 1 Enzymes

  2016cites this paper
• Cancer Activation and Polymorphisms of Human Cytochrome P450 1B1

  2016cites this paper
• Genetic Polymorphisms of Cytochrome P450 and Antidepressants

  2016cites this paper
• Determination of CYP2C19 polymorphism, side effects, and medication adherence in patients who have utilized selective serotonin reuptake inhibitors -

  2016cites this paper
• Determination of CYP 2 C 19 Polymorphism , Side Effects , and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors

  2016cites this paper
• An improved large-scale prediction model of CYP1A2 inhibitors by using combined fragment descriptors

  2015cites this paper
• MicroRNA regulation of the major drug-metabolizing enzymes and related transcription factors

  2015cites this paper
• Analgesic effects of topical ketamine.

  2015cites this paper
• Functional Significance of Cytochrome P450 1A2 Allelic Variants, P450 1A2*8, *15, and *16 (R456H, P42R, and R377Q)

  2015influential citation
• In vitro functional analysis of 24 novel CYP2C19 variants recently found in the Chinese Han population

  2015cites this paper
• Characterisation of the Metabolites of 1,8-Cineole Transferred into Human Milk: Concentrations and Ratio of Enantiomers

  2013cites this paper
• Analysis of Substrate Recognition Site 2 (SRS2) in human cytochrome P450 1A2 using whole-plasmid random mutagenesis

  2013cites this paper
• Pharmacokinetics of Rifabutin in Japanese HIV-Infected Patients with or without Antiretroviral Therapy

  2013cites this paper
• Étude des interactions protéiques entre les formes d'épissage du gène UGT1A

  2013cites this paper
• Douleur chronique : rôle de la pharmacogénétique dans la résistance aux antidépresseurs

  2013cites this paper
• Functional influence of human CYP2D6 allelic variations: P34S, E418K, S486T, and R296C

  2013cites this paper
• Practical and clinical use of opioids

  2013cites this paper
• Application of drug metabolism and pharmacokinetics for new drug development

  2011cites this paper